retatrutide kick in time – The New Weight Loss Helper Retatrutide is a new medication being developed by Eli Lilly to help people lose weight. It's like a super version of drugs such as Ozempic Retatrutide Timeline: When to Expect

Other major holdings for all three products include Eli Lilly & Co., Zealand Pharma and Roche Holding AG

Pfizer, after discontinuing its initial danuglipron candidate due to safety concerns in April 2025, re-entered the race through a $10 billion acquisition of clinical-stage biotech Metsera in November 2025, securing a next-generation obesity pipeline [43]

Garvey WT et al

The patient was admitted and observed

This increased intestinal length and villus height from Glucagon-like peptide-1 seem to contribute to an elevated risk of bowel injuries

A real-world study followed individuals who started GLP-1 medications and discontinued them within 3 to 12 months to assess weight changes after stopping treatment